Cargando…
Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre
Systemic lupus erythematosus (SLE) is a relatively common autoimmune disease with recently reported cases of lupus-associated protein-losing enteropathy (LUPLE) as an unusual manifestation. It is a well-recognized clinical entity predominantly affecting middle-aged Asian females. LUPLE is diagnosed...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301274/ https://www.ncbi.nlm.nih.gov/pubmed/34327069 http://dx.doi.org/10.7759/cureus.15826 |
_version_ | 1783726630348259328 |
---|---|
author | Prabasara, Kasun Sundaresan, K T Rosa, Chamith |
author_facet | Prabasara, Kasun Sundaresan, K T Rosa, Chamith |
author_sort | Prabasara, Kasun |
collection | PubMed |
description | Systemic lupus erythematosus (SLE) is a relatively common autoimmune disease with recently reported cases of lupus-associated protein-losing enteropathy (LUPLE) as an unusual manifestation. It is a well-recognized clinical entity predominantly affecting middle-aged Asian females. LUPLE is diagnosed by exclusion of possible causes for hypoalbuminemia in a patient with positive anti-nuclear antibody (ANA). LUPLE as the first manifestation of SLE is rare but it is a well-recognized complication secondary to SLE. We report a case of a 39-year-old Sri Lankan lady who was investigated for generalized body swelling, pleural effusions, ascites and pericardial effusions due to hypoalbuminemia. Her ANA was positive with speckled pattern and intestinal biopsy samples revealed evidences of chronic inflammatory cell infiltrates in laminapropria. Her investigations were not suggestive of liver diseases, albuminuria or malnutrition. We excluded all possible etiologies for protein-losing enteropathy although gold standard tests to confirm it was not available in our center. In conclusion, LUPLE should be considered as an etiology for all the unexplained protein-losing enteropathies. We suggest to treat LUPLE with prednisolone, hydroxychloroquine (HCQ) followed by steroid-sparing agents such as azathioprine. Prognosis was excellent following appropriate treatment. |
format | Online Article Text |
id | pubmed-8301274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-83012742021-07-28 Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre Prabasara, Kasun Sundaresan, K T Rosa, Chamith Cureus Rheumatology Systemic lupus erythematosus (SLE) is a relatively common autoimmune disease with recently reported cases of lupus-associated protein-losing enteropathy (LUPLE) as an unusual manifestation. It is a well-recognized clinical entity predominantly affecting middle-aged Asian females. LUPLE is diagnosed by exclusion of possible causes for hypoalbuminemia in a patient with positive anti-nuclear antibody (ANA). LUPLE as the first manifestation of SLE is rare but it is a well-recognized complication secondary to SLE. We report a case of a 39-year-old Sri Lankan lady who was investigated for generalized body swelling, pleural effusions, ascites and pericardial effusions due to hypoalbuminemia. Her ANA was positive with speckled pattern and intestinal biopsy samples revealed evidences of chronic inflammatory cell infiltrates in laminapropria. Her investigations were not suggestive of liver diseases, albuminuria or malnutrition. We excluded all possible etiologies for protein-losing enteropathy although gold standard tests to confirm it was not available in our center. In conclusion, LUPLE should be considered as an etiology for all the unexplained protein-losing enteropathies. We suggest to treat LUPLE with prednisolone, hydroxychloroquine (HCQ) followed by steroid-sparing agents such as azathioprine. Prognosis was excellent following appropriate treatment. Cureus 2021-06-22 /pmc/articles/PMC8301274/ /pubmed/34327069 http://dx.doi.org/10.7759/cureus.15826 Text en Copyright © 2021, Prabasara et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Rheumatology Prabasara, Kasun Sundaresan, K T Rosa, Chamith Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre |
title | Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre |
title_full | Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre |
title_fullStr | Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre |
title_full_unstemmed | Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre |
title_short | Isolated Lupus-Associated Protein-Losing Enteropathy in a Resource-Limited Centre |
title_sort | isolated lupus-associated protein-losing enteropathy in a resource-limited centre |
topic | Rheumatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301274/ https://www.ncbi.nlm.nih.gov/pubmed/34327069 http://dx.doi.org/10.7759/cureus.15826 |
work_keys_str_mv | AT prabasarakasun isolatedlupusassociatedproteinlosingenteropathyinaresourcelimitedcentre AT sundaresankt isolatedlupusassociatedproteinlosingenteropathyinaresourcelimitedcentre AT rosachamith isolatedlupusassociatedproteinlosingenteropathyinaresourcelimitedcentre |